Raphas Co. Ltd (214260) - Total Liabilities

Latest as of September 2025: ₩50.14 Billion KRW ≈ $33.98 Million USD

Based on the latest financial reports, Raphas Co. Ltd (214260) has total liabilities worth ₩50.14 Billion KRW (≈ $33.98 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Raphas Co. Ltd cash conversion from operations to assess how effectively this company generates cash.

Raphas Co. Ltd - Total Liabilities Trend (2017–2024)

This chart illustrates how Raphas Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Raphas Co. Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Raphas Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Raphas Co. Ltd ranked by their total liabilities.

Company Country Total Liabilities
Rushil Decor Limited
NSE:RUSHIL
India Rs6.36 Billion
Leader Electronics Inc
TW:3058
Taiwan NT$3.03 Billion
Speciality Restaurants Limited
NSE:SPECIALITY
India Rs1.99 Billion
Evrofarma SA
AT:EVROF
Greece €34.79 Million
Archer Materials Ltd
AU:AXE
Australia AU$752.16K
Changhae Ethanol Co. Ltd
KQ:004650
Korea ₩50.91 Billion
PS International Group Ltd. Ordinary Shares
NASDAQ:PSIG
USA $4.53 Million
Purple Innovation Inc
NASDAQ:PRPL
USA $329.03 Million

Liability Composition Analysis (2017–2024)

This chart breaks down Raphas Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Raphas Co. Ltd (214260) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.83 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.67 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.61 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Raphas Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Raphas Co. Ltd (2017–2024)

The table below shows the annual total liabilities of Raphas Co. Ltd from 2017 to 2024.

Year Total Liabilities Change
2024-12-31 ₩46.73 Billion
≈ $31.67 Million
-31.37%
2023-12-31 ₩68.10 Billion
≈ $46.15 Million
+23.51%
2022-12-31 ₩55.13 Billion
≈ $37.36 Million
+21.21%
2021-12-31 ₩45.49 Billion
≈ $30.82 Million
+190.71%
2020-12-31 ₩15.65 Billion
≈ $10.60 Million
+3.95%
2019-12-31 ₩15.05 Billion
≈ $10.20 Million
+4.67%
2018-12-31 ₩14.38 Billion
≈ $9.75 Million
+29.90%
2017-12-31 ₩11.07 Billion
≈ $7.50 Million
--

About Raphas Co. Ltd

KQ:214260 Korea Biotechnology
Market Cap
$54.13 Million
₩79.88 Billion KRW
Market Cap Rank
#21593 Global
#1397 in Korea
Share Price
₩9500.00
Change (1 day)
-1.96%
52-Week Range
₩9320.00 - ₩21150.00
All Time High
₩75400.00
About

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organiza… Read more